Regional Support & Consultant at MedDRA MSSO | Founder of Signal Management Unit at EPVC, EDA
The risks and benefits of medication use in pregnancy are typically established through the postmarketing product-life cycle. Here is an example of the crucial importance of reporting drug exposure during pregnancy and how risks can be confounded by indication and improper management of chronic diseases. #Pharmacovigilance #Pregnancy #Diabetes #AdverseOutcomes
Diabetes mellitus is widely prevalent in Egypt, with insulin products often used as the first line of treatment in pregnant women. What can Egyptian postmarketing #pharmacovigilance data tell us about uncompleted pregnancy following #insulin exposure? Heba Ibrahim, Qun-Ying Yue, and Boukje Raemaekers, MD explore in this scientific poster presented at #ISoPBali2023 👉 ow.ly/o31550Qbv8P ISoP Online Egyptian Drug Authority
